维普期刊资源整合服务平台（V6.5）

23篇 您的检索式：作者名="HASSLACHER C"

选中清除导出查看参考文献查看引证文献引用追踪共2页首页上一页第1页下一页末页 /2 跳转

	题名	作者	年代	出处	被引量
1	Safety and efficacy of repaglinide in type 2 diabetic patients with and without impaired renal function显示文摘	Hasslacher C Multinational Repaglinide Renal Study Group	2003	Diabetes Care2003，26，3：	1
2	Levosimendan in-hibits release of reactive oxygen species in polymorphonuclearleukocytes in vitro and in patients with acute heart failure andseptic shock:aprospective observational study显示文摘	Hasslacher J Bijuklic K Bertocchi C	2011	Crit Care2011，15，4：	1
3	Influence of calcium dobesilate on the raised synthesis of basement membrane collagen in diabetic rats显示文摘	Hasslacher C Burklin E Kopischke HG	1980	Res Exp Med (Berl)1980，178，1：	1
4	Nanotubes in microwave fields : Light emission, intense heat, outgassing, and reconstruction 显示文摘	Imholt T J Dyke C A Hasslacher B	2003	Chem Mater2003，15，21：	1
5	Effect of insulin analogs on the decline of hemoglobin in diabetic patients with nephropathy显示文摘	HASSLACHER C COLLENBERG E MOCKS J	2010	Exp Clin Endocrinol Diabetes2010，118，6：	1
6	Levosimendan inhibits release of reactive Oxygen species in polymorphonuclear leukocytes in vitro and in patients with acute heart failure and septic shock:a prospective observational study显示文摘	Hasslacher J Bijuklic K Bertocchi C	2011	Crit Care2011，15，4：	1
7	Therapy of diabetic nephropathy显示文摘	Ritz E	1985	Dtsch Med Wochenschr1985，110，43：	1
8	Safety and efficacy of repaglinide in type 2 diabetic patients with and without impaired renal function显示文摘	Hasslacher C Multinational Repaglinide Renal Study Group	2003	Diabetes Care2003，26，3：	1
9	Safety and efficacy of repaglinide in type 2 dia- betic patients with and without impaired renal function 显示文摘	Hasslacher C Multinational Repaglinide Renal Study Group	2003	Diabetes Care2003，26，3：	1
10	Effect of insulin analogs on the decline of hemoglobin in diabetic patients with nephropathy 显示文摘	Hasslacher C Collenberg E Mocks J	2010	Exp Clini Endoerinolo Diabetes2010，118，3：	1
11	Safety and efficacy of repaglinide in type 2 diabetic patients with and without impaired renal function显示文摘	HASSLACHER C	2003	Diabetes Care2003，26，：	1
12	Inhibition of increased synthesis of glomerular basement membrane collagen in diabetic rats in vivo显示文摘	Hasslacher C Burklin E Kopischke H G	1981	Ren Physiol1981，4，23：	1
13	Levosimendan inhibits release of reactive oxygen species in polymorphonuclear leukocytes in vitro and in patients with acute heart failure and septic shock:aprospective observational study显示文摘	Hasslacher J Bijuklic K Bertocchi C	2011	Crit Care2011，15，4：	1
14	Urinary glycosylated,free and total pyridinium and free and total hydroxypyridinium in diabetes mellitus显示文摘	WAHLT P HASSLACHER C	1998	Clin Endocrinol1998，48，：	1
15	Western blotting of NC1 type Ⅳ collagen fragments in human plasma显示文摘	HAO L HASSLACHER C	1997	Eur J Clin Invest1997，27，7：	1
16	Severe hypoglycemia in diabetics with impaired renal function ] 显示文摘	Hasslacher C Wittmann W	2003	Dtsch Med Wochenschr2003，128，6：	1
17	Sinier risks of nephropathy in patients with type 1 or type 2 diabetes mellitus显示文摘	Ritz Rillt E	1989	Nephrol Dial Transplant1989，4，：	1
18	Levosi-mendan inhibits release of reactive oxygen species in polymorphonuclear leukocytes in vitro and in patients withacute heart failure and septic shock: a pros pective ob-servational study显示文摘	Hasslacher J Bijuklic K Bertocchi C	2011	Crit Care2011，15，4：	1
19	Analytical performance of glucose monitoring systems at different blood glucose ranges and a-nalysis of outliers in a clinical setting显示文摘	Hasslacher C Kulozik F Platten I	2014	J Diabetes Sci Technol2014，8，3：	1
20	Safety and efficacy of repaglinide in trpe 2 diabedetic patients with and without impaired renal function显示文摘	Hasslacher C	2003	Diabetes care2003，26，：	1

返回顶部每页显示：

共2页首页上一页第1页下一页末页 /2 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示